Patents by Inventor Inga Flor

Inga Flor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Expression of miRNAs in Placental Tissue
    Publication number: 20220033822
    Abstract: Provided are human miRNAs associated with the generation of immunological tolerance during pregnancy as well as fragments, derivatives and variants thereof for use in immunomodulation. Said miRNAs may be used in diagnosis and treatment of disorders associated with a deregulated immune response, autoimmune disorders, pregnancy associated diseases, failure or problems of placentation and complications resulting from allotransplantations. In addition, new pharmaceutical and diagnostic compositions for use in diagnosis and therapy of said disorders are described.
    Type: Application
    Filed: October 20, 2021
    Publication date: February 3, 2022
    Inventors: Jorn Bullerdiek, Inga Flor
  • Detection of nucleic acid molecules
    Patent number: 10889855
    Abstract: The present invention relates to methods for the detection of nucleic acid molecules at the lower detection limit.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: January 12, 2021
    Assignee: miRdetect GmbH
    Inventors: Meike Spiekermann, Nina Winter, Inga Flor, Gazanfer Belge
  • Detection of Nucleic Acid Molecules
    Publication number: 20180163264
    Abstract: The present invention relates to methods for the detection of nucleic acid molecules at the lower detection limit.
    Type: Application
    Filed: April 29, 2016
    Publication date: June 14, 2018
    Inventors: Meike SPIEKERMANN, Nina WINTER, Inga FLOR, Gazanfer BELGE
  • EXPRESSION OF MIRNAS IN PLACENTAL TISSUE
    Publication number: 20170114343
    Abstract: Provided are human miRNAs associated with the generation of immunological tolerance during pregnancy as well as fragments, derivatives and variants thereof for use in immunomodulation. Said miRNAs may be used in diagnosis and treatment of disorders associated with a deregulated immune response, autoimmune disorders, pregnancy associated diseases, failure or problems of placentation and complications resulting from allotransplantations. In addition, new pharmaceutical and diagnostic compositions for use in diagnosis and therapy of said disorders are described.
    Type: Application
    Filed: December 9, 2016
    Publication date: April 27, 2017
    Inventors: Jorn BULLERDIEK, Inga FLOR
  • EXPRESSION OF MIRNAS IN PLACENTAL TISSUE
    Publication number: 20140294840
    Abstract: Provided are human miRNAs associated with the generation of immunological tolerance during pregnancy as well as fragments, derivatives and variants thereof for use in immunomodulation. Said miRNAs may be used in diagnosis and treatment of disorders associated with a deregulated immune response, autoimmune disorders, pregnancy associated diseases, failure or problems of placentation and complications resulting from allotransplantations. In addition, new pharmaceutical and diagnostic compositions for use in diagnosis and therapy of said disorders are described.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 2, 2014
    Inventors: Jorn Bullerdiek, Inga Flor